WHO WE ARE:

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.

SKILLS AND EXPERIENCE YOU’LL BRING:

• Advanced degree in life sciences or related field (PhD, PharmD, or MD preferred).
• 15+ years of clinical operations leadership experience, with a strong track record managing global trials across phases (esp. Ph2–Ph3), ideally in immunology/inflammation and/or large scale trials.
• Demonstrated success building and leading large, multi-disciplinary teams in dynamic, matrixed environments.
• Expertise in vendor oversight, budget and resource planning, and cross-functional team alignment.
• Deep understanding of regulatory requirements and global GCP/ICH guidelines.
• Inspirational people leader with excellent communication, decision-making, and change management skills.
• Mission-driven, solutions-oriented, and thrives in a fast-paced biotech setting.

Please refer the Job description for details